Showing results (71-80 of 210) with videos related to

Sort By:
Pageof 21
Cephalalgia : an International Journal of Headache|October 27, 2010
TRPV1 receptor blockade is ineffective in different in vivo models of migraineOliver Summ, Philip R Holland, Simon Akerman, et al.
Expert Review of Neurotherapeutics|February 23, 2019
Neuromodulation for the treatment of primary headache syndromesJan Hoffmann, Arne May
Cephalalgia : an International Journal of Headache|February 26, 2021
Diagnosis and treatment of idiopathic intracranial hypertensionNaz Raoof, Jan Hoffmann
The Lancet. Neurology|November 28, 2017
Diagnosis, pathophysiology, and management of cluster headacheJan Hoffmann, Arne May
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 7, 2018
Glutamate and Its Receptors as Therapeutic Targets for MigraineJan Hoffmann, Andrew Charles
Journal of Clinical Medicine|July 29, 2025
Insights into Vestibular Migraine: Diagnostic Challenges, Differential Spectrum and Therapeutic HorizonsMarlon Cantillo-Martínez, Joan Lorente-Piera, Raquel Manrique-Huarte, et al.
Pain|July 27, 2010
Inhibition of trigeminovascular dural nociceptive afferents by Ca(2+)-activated K(+) (MaxiK/BK(Ca)) channel openingSimon Akerman, Philip R Holland, Michele P Lasalandra, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 13, 2013
Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraineSimon Akerman, Philip R Holland, Michele P Lasalandra, et al.
Pain|March 7, 2020
PAC1 receptor blockade reduces central nociceptive activity: new approach for primary headache?Jan Hoffmann, Silke Miller, Margarida Martins-Oliveira, et al.
Pageof 21